跳至主要内容
临床试验/JPRN-jRCTs071200019
JPRN-jRCTs071200019已完成2 期

A phase 2study of chemoradiation with use of weekly carboplatin and concurrent radiotherapy for local advanced non-small cell lung cancer in elderly patients - LOGIK1902

Harada Taishi0 个研究点目标入组 45 人开始时间: 2020年6月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 75age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Patients with histologically or cytologically confirmed non-small cell lung cancer.
  • 2)No prior history of chemotherapy, thoracic radiotherapy or surgical resection
  • 3)Unresectable stage 3disease.
  • 4)V20 is under 35%.
  • 5)There is measurable region.
  • 6)Age>=75
  • 7)Eastern Cooperative Oncology Group performance status=<1
  • 8)Leucocyte>=4000/mm3, Neutrocyte>=2000/mm3, platelets>=100000/mm3, hemoglobin>=9.0g/dl, AST and ALT=<100, bilirubin=<1.5mg/dl and serum creatinine=<1.5mg/dl. PaO2>=65torr or SpO2>=92%
  • 9)Written informed consent.

排除标准

  • 1)Involvement of contralateral hilar lymph nodes.
  • 2)Interstitial pneumonia or pulmonary fibrosis detected with chest X-ray.
  • 3)SVC syndrome.
  • 4)Obstructive pneumonia or active severe infection.
  • 5)Other active invasive malignancies
  • 6)Severe complications such as gastrointestinal bleeding, significant heart failure or uncontrolled diabetes and so on.
  • 7)History of severe hypersensitivity.
  • 8)Regular use of corticosteroids.
  • 9)Mental illness
  • 10)Pregnant woman and lactating woman
  • 11)Active hepatitis B
  • 12)A case considered by an investigator inadequate for the trial.

研究者

发起方
Harada Taishi

相似试验